Interior wall paint has been infused with anti-mold and anti-fungal properties for years, but a paint that can kill MRSA?
Developed for healthcare environments, Sherwin-Williams’ new Paint Shield is the first EPA-registered interior latex microbicidal paint that kills more than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycin-resistant Enterococcus faecalis) and Enterobacter aerogenes on painted surfaces within two hours of exposure. Even better, a properly painted surface continues to kill 90 percent of bacteria for up to four years when the integrity of the surface is maintained, according to the company’s product specifications.
Facilities don’t need to settle for “institutional green,” either. The paint comes in a white base that can be mixed with a range of 550 color tints and depths.
Topics: Clinical , Clinical Leadership , Operations